ArticleInvestigational new drugs2018

Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone.

Giandomenico Roviello et al.PubMed ↗Publisher ↗

No numbers read from the abstract.